Latest News for 09/2020
27 Aug 2020
Scientists at the Wellcome Centre for Anti-Infectives Research (WCAIR) at the University of Dundee have been awarded £4.9million in follow-on funding from the Wellcome Trust, boosting their efforts to understand more about potential drugs that could be used to treat neglected tropical diseases (NTDs) and other parasitic diseases.
25 Jul 2019
Dr Susan Wyllie, Head of the Mode of Action (MoA) group, has been promoted to tenure track Principal Investigator in the School. Her group is part of the Division of Biological Chemistry and Drug Discovery (BCDD) and the Wellcome Centre for Anti-Infectives Research (WCAIR). Background
12 Feb 2019
Researchers in the Wellcome Centre for Anti-Infectives Research (WCAIR) have been awarded £700,000 to investigate whether bacteria and other natural products found in the Amazon hold the key to developing new drugs for neglected tropical diseases. The team led by Professor Kevin Read will work with colleagues in Brazil to identify novel drug targets and develop new therapies for visceral leishmaniasis and Chagas’ disease.
10 Oct 2018
In a novel twist for researchers who actively develop drugs to combat tropical diseases, a group of scientists at the University of Dundee have been honoured for putting an end to a promising piece of research.
04 Sep 2018
Researchers at the University of Dundee have identified a new drug target in parasites that cause major neglected tropical diseases, a discovery that contributes towards a global drive to eliminate these diseases by 2030.
25 Jul 2018
A new preclinical candidate drug with the potential to treat visceral leishmaniasis, one of the world’s major neglected diseases, has been discovered through a close collaboration between the University of Dundee, GSK and Wellcome.